5976 - 6000 of 8125 Results
Title
Year
-
OPENTitle: Associations Between Tau, β-Amyloid, and Cognition in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 75Issue #: 2Start Page: 227End Page: 227Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2017.3713Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2664949/jamaneurology_winer_2017_oi_170089.pdfCitation Count: 59
-
OPENTitle: The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1Journal Name: ChemBioChemPublisher: WileyVol: 19Issue #: 5Start Page: 425End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cbic.201700500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cbic.201700500Citation Count: 49
-
OPENTitle: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 3End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006Best OA location URL: https://europepmc.org/articles/pmc5803409?pdf=renderCitation Count: 47
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://doi.org/10.15252/embj.201798099Citation Count: 325
-
OPENTitle: Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long termJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 135Issue #: 1Start Page: 65End Page: 83Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1792-9Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00401-017-1792-9.pdfCitation Count: 178
-
OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27232Citation Count: 134
-
OPENTitle: Effects of Exercise on Non-motor Symptoms in Parkinson’s DiseaseJournal Name: Clinical TherapeuticsPublisher: Elsevier BVVol: 40Issue #: 1Start Page: 8End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.clinthera.2017.11.004Best OA location URL: http://www.clinicaltherapeutics.com/article/S0149291817310664/pdfCitation Count: 90
-
OPENTitle: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synucleinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 110Issue #:Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006Best OA location URL: http://manuscript.elsevier.com/S0969996117302723/pdf/S0969996117302723.pdfCitation Count: 44
-
RESTRICTEDTitle: Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 236End Page: 245Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.07.019Best OA location URL: https://doi.org/10.1016/j.expneurol.2017.07.019Citation Count: 128
-
RESTRICTEDTitle: Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 202End Page: 209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.08.001Best OA location URL: https://europepmc.org/articles/pmc6037988?pdf=renderCitation Count: 74
-
OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 31
-
OPENTitle: Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomiaJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 28Issue #: 1Start Page: 125End Page: 126Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-017-0487-6Best OA location URL: https://europepmc.org/articles/pmc5807189?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.001Citation Count: 50
-
OPENTitle: Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)Journal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e016904End Page: e016904Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-016904Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e016904.full.pdfCitation Count: 7
-
RESTRICTEDTitle: Targeting urate to reduce oxidative stress in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 210End Page: 224Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.06.017Best OA location URL: http://manuscript.elsevier.com/S0014488617301577/pdf/S0014488617301577.pdfCitation Count: 103
-
RESTRICTEDTitle: Therapeutic approaches to target alpha-synuclein pathologyJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 225End Page: 235Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.003Best OA location URL: http://manuscript.elsevier.com/S0014488617302455/pdf/S0014488617302455.pdfCitation Count: 192
-
OPENTitle: A proteomic network approach across the ALS ‐ FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brainJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 48End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201708202Best OA location URL: https://doi.org/10.15252/emmm.201708202Citation Count: 143
-
OPENTitle: Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin DownregulationJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 9Issue #: 6Start Page: 1853End Page: 1867Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2017.10.029Best OA location URL: http://www.cell.com/article/S2213671117304848/pdfCitation Count: 46
-
RESTRICTEDTitle: Applying a community-based participatory research framework to patient and family engagement in the development of patient-centered outcomes research and practiceJournal Name: Translational Behavioral MedicinePublisher: Oxford University Press (OUP)Vol: 8Issue #: 5Start Page: 683End Page: 691Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/tbm/ibx026Best OA location URL: https://academic.oup.com/tbm/article-pdf/8/5/683/25699129/ibx026.pdfCitation Count: 72
-
OPENTitle: Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?Journal Name: EJNMMI PhysicsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40658-017-0196-1Best OA location URL: https://ejnmmiphys.springeropen.com/track/pdf/10.1186/s40658-017-0196-1Citation Count: 32
-
RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
-
OPENTitle: Exploring the reproducibility of functional connectivity alterations in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 11Start Page: e0188196End Page: e0188196Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0188196Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0188196&type=printableCitation Count: 74
-
OPENTitle: Orthostatic hypotension in Parkinson disease: Impact on health care utilizationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 45End Page: 49Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.11.344Best OA location URL: https://zenodo.org/records/3830895/files/PARKRELDIS-S-17-01092_1.pdfCitation Count: 39
-
OPENTitle: Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 2Start Page: 486End Page: 495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awx344Best OA location URL: https://academic.oup.com/brain/article-pdf/141/2/486/24175904/awx344.pdfCitation Count: 42
-
OPENTitle: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilienceJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13073-017-0486-1Best OA location URL: https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-017-0486-1Citation Count: 82